Gaucher-kór: vizsgálatok itt: Pakisztán
2 trials · From ClinicalTrials.gov, checked 2026. november 13.. Ask the study team whether a trial fits you.
- 2. fázisNot yet taking people in PakisztánStudy to Evaluate the Efficacy and Safety of Nizubaglustat (AZ-3102) in Patients With Gaucher Disease Type 3 (GD3)
- Where
- Lahore, Peshawar
- Életkor
- 4 év to 30 év
- People
- 20 worldwide
- Run by
- Azafaros B.V.
See details and how to joinNCT07715084 - No phaseTaking peopleInternational Collaborative Gaucher Group (ICGG) Gaucher Disease Registry & Pregnancy Sub-registry
- Where
- Karachi, Lahore
- People
- 12 000 worldwide
- Run by
- Genzyme, a Sanofi Company
See details and how to joinNCT00358943